Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes
暂无分享,去创建一个
J. Hasty | R. Knight | R. A. Richter | A. Saghatelian | A. C. Dantas Machado | L. Eckmann | S. Ho | Y. Miyamoto | A. Zarrinpar | Ana Carolina Dantas Machado | Anand R. Saran | Steven D. Brown | Amulya Lingaraju | Antonio F. M. Pinto | Nicole Siguenza | R. Richter | Baylee J. Russell | Irene Mai | E. Maissy | R. Knight | Amir Zarrinpar
[1] A. Saghatelian,et al. Diet and feeding pattern modulate diurnal dynamics of the ileal microbiome and transcriptome , 2022, Cell reports.
[2] D. Artis,et al. Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome , 2022, Cell.
[3] Benjamin E. Rubin,et al. Species- and site-specific genome editing in complex bacterial communities , 2021, Nature Microbiology.
[4] W. S. Denney,et al. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study , 2021, Nature Metabolism.
[5] Jiachao Zhang,et al. Candidate probiotic Lactiplantibacillus plantarum HNU082 rapidly and convergently evolves within human, mice, and zebrafish gut but differentially influences the resident microbiome , 2021, Microbiome.
[6] Emmanuel O. Elijah,et al. Intermittent Hypoxia and Hypercapnia Alter Diurnal Rhythms of Luminal Gut Microbiome and Metabolome , 2021, mSystems.
[7] Emmanuel O. Elijah,et al. Influence of Intermittent Hypoxia/Hypercapnia on Atherosclerosis, Gut Microbiome, and Metabolome , 2021, Frontiers in Physiology.
[8] J. Hasty,et al. The microbiome and human cancer , 2021, Science.
[9] V. G. Thackray,et al. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome , 2020, Journal of the Endocrine Society.
[10] Micah B. Hartman,et al. National Health Care Spending In 2019: Steady Growth For The Fourth Consecutive Year. , 2020, Health affairs.
[11] Benjamin D. Kaehler,et al. RESCRIPt: Reproducible sequence taxonomy reference database management , 2020, bioRxiv.
[12] K. Clément,et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders , 2020, Nature Reviews Gastroenterology & Hepatology.
[13] H. Holman. The Relation of the Chronic Disease Epidemic to the Health Care Crisis , 2020, ACR open rheumatology.
[14] A. Zarrinpar,et al. Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease. , 2020, Gastroenterology.
[15] R. Rodrigues,et al. Role of gut microbiota in type 2 diabetes pathophysiology , 2020, EBioMedicine.
[16] P. Malhotra,et al. Intestinal Absorption of Bile Acids in Health and Disease. , 2019, Comprehensive Physiology.
[17] L. Eckmann,et al. Evaluation of Peroxides and Chlorine Oxides as Disinfectants for Chemical Sterilization of Gnotobiotic Rodent Isolators. , 2019, Journal of the American Association for Laboratory Animal Science : JAALAS.
[18] Francesco Asnicar,et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.
[19] Kevin S. Bonham,et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.
[20] G. Muscogiuri,et al. Gut microbiota: a new path to treat obesity , 2019, International journal of obesity supplements.
[21] Harris H. Wang,et al. Metagenomic engineering of the mammalian gut microbiome in situ , 2018, Nature Methods.
[22] G. Lewis,et al. Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms , 2018, Cellular and molecular gastroenterology and hepatology.
[23] Danielle B Pedrolli,et al. Engineering Microbial Living Therapeutics: The Synthetic Biology Toolbox. , 2019, Trends in biotechnology.
[24] P. Silver,et al. Escherichia coli NGF-1, a Genetically Tractable, Efficiently Colonizing Murine Gut Isolate , 2018, Microbiology Resource Announcements.
[25] R. Parthasarathy,et al. Modernized Tools for Streamlined Genetic Manipulation and Comparative Study of Wild and Diverse Proteobacterial Lineages , 2018, mBio.
[26] M. V. D. van der Heijden,et al. Keystone taxa as drivers of microbiome structure and functioning , 2018, Nature Reviews Microbiology.
[27] Dimitra N. Stratis-Cullum,et al. Engineered integrative and conjugative elements for efficient and inducible DNA transfer to undomesticated bacteria , 2018, Nature Microbiology.
[28] Adam B Fisher,et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria , 2018, Nature Biotechnology.
[29] R. Knight,et al. Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism , 2018, Nature Communications.
[30] Amir I. Mina,et al. A selective gut bacterial bile salt hydrolase alters host metabolism , 2018, eLife.
[31] Bin Wang,et al. Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut , 2018, bioRxiv.
[32] Michel Sadelain,et al. Chimeric Antigen Receptor Therapy. , 2018, The New England journal of medicine.
[33] Nikhil U. Nair,et al. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications. , 2018, Annual review of biomedical engineering.
[34] Weston R. Whitaker,et al. An exclusive metabolic niche enables strain engraftment in the gut microbiota , 2018, Nature.
[35] A. Myc,et al. Comparison of Commensal Escherichia coli Isolates from Adults and Young Children in Lubuskie Province, Poland: Virulence Potential, Phylogeny and Antimicrobial Resistance , 2018, International journal of environmental research and public health.
[36] Rob Knight,et al. American Gut: an Open Platform for Citizen Science Microbiome Research , 2018, mSystems.
[37] Pamela A. Silver,et al. Engineering bacteria for diagnostic and therapeutic applications , 2018, Nature Reviews Microbiology.
[38] Benjamin D. Kaehler,et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin , 2018, Microbiome.
[39] Adam M. Phillippy,et al. MUMmer4: A fast and versatile genome alignment system , 2018, PLoS Comput. Biol..
[40] A. Saraiva,et al. Worldwide Phylogenetic Group Patterns of Escherichia coli from Commensal Human and Wastewater Treatment Plant Isolates , 2017, Front. Microbiol..
[41] Xun Xu,et al. The gut microbiome in atherosclerotic cardiovascular disease , 2017, Nature Communications.
[42] Finn Stirling,et al. Rational Design of Evolutionarily Stable Microbial Kill Switches. , 2017, Molecular cell.
[43] Michael Baym,et al. Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation , 2017, Nature Biotechnology.
[44] Michael Zimmermann,et al. Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut , 2017, Cell.
[45] Weston R. Whitaker,et al. Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome , 2017, Cell.
[46] Jose A Navas-Molina,et al. Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns , 2017, mSystems.
[47] K. Aagaard,et al. Maturation of the Infant Microbiome Community Structure and Function Across Multiple Body Sites and in Relation to Mode of Delivery , 2017, Nature Medicine.
[48] P. Gérard,et al. Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria , 2017, Analytical and Bioanalytical Chemistry.
[49] Timothy K Lu,et al. Microbiome therapeutics - Advances and challenges. , 2016, Advanced drug delivery reviews.
[50] Hanns-Ulrich Marschall,et al. Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism. , 2016, Cell metabolism.
[51] Oluf Pedersen,et al. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials , 2016, Genome Medicine.
[52] P. Bork,et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation , 2016, Science.
[53] S. Essack,et al. Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda , 2016, BMC Research Notes.
[54] Harris H. Wang,et al. Manipulating Bacterial Communities by in situ Microbiome Engineering. , 2016, Trends in genetics : TIG.
[55] Thomas D Young,et al. Tools for the Microbiome: Nano and Beyond. , 2015, ACS nano.
[56] Timothy K Lu,et al. Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota. , 2015, Cell systems.
[57] Rob Knight,et al. Analysis of composition of microbiomes: a novel method for studying microbial composition , 2015, Microbial ecology in health and disease.
[58] Michael A. Fischbach,et al. Synthetic Microbes As Drug Delivery Systems , 2014, ACS synthetic biology.
[59] S. Yooseph,et al. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. , 2014, Cell metabolism.
[60] C. Hill,et al. Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk , 2014, Gut microbes.
[61] C. Hill,et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut , 2014, Proceedings of the National Academy of Sciences.
[62] Jean M. Macklaim,et al. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis , 2014, Microbiome.
[63] A. Kostic,et al. The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.
[64] James J Collins,et al. Programmable bacteria detect and record an environmental signal in the mammalian gut , 2014, Proceedings of the National Academy of Sciences.
[65] M. Goulian,et al. Escherichia coli Isolate for Studying Colonization of the Mouse Intestine and Its Application to Two-Component Signaling Knockouts , 2014, Journal of bacteriology.
[66] F. Bäckhed,et al. Microbial modulation of energy availability in the colon regulates intestinal transit. , 2013, Cell host & microbe.
[67] Klaus Ley,et al. Bacterial colonization factors control specificity and stability of the gut microbiota , 2013, Nature.
[68] B. Mayo,et al. Mobilome and genetic modification of bifidobacteria. , 2013, Beneficial microbes.
[69] J. Chatel,et al. Engineering lactococci and lactobacilli for human health. , 2013, Current opinion in microbiology.
[70] Fredrik H. Karlsson,et al. Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.
[71] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[72] A. Klindworth,et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies , 2012, Nucleic acids research.
[73] Qiang Feng,et al. A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.
[74] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[75] Jeremy L. Pinyon,et al. Commensal Escherichia coli of healthy humans: a reservoir for antibiotic-resistance determinants. , 2010, Journal of medical microbiology.
[76] Q. Fu,et al. Phylogenetic Groups and Pathogenicity Island Markers in Fecal Escherichia coli Isolates from Asymptomatic Humans in China , 2010, Applied and Environmental Microbiology.
[77] B. Roe,et al. A core gut microbiome in obese and lean twins , 2008, Nature.
[78] Colin Hill,et al. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome , 2008, Proceedings of the National Academy of Sciences.
[79] Erik Remaut,et al. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[80] W. Fiers,et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.
[81] R. Walker,et al. Intestinal barriers to bacteria and their toxins. , 1990, Annual review of medicine.
[82] I. Leodolter. [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.